Cabot Guides FY2027 Adjusted EPS to $6.15-$6.75 After Q4 Adjusted EPS of $1.61
CBT sits 28% above its 52-week low of $58.33.
Summary
Cabot reported fourth-quarter adjusted EPS of $1.61 and full-year adjusted EPS of $6.42, then guided fiscal 2027 adjusted EPS to $6.15-$6.75 — a midpoint below the year just finished. Reinforcement Materials profit fell on weaker pricing, while Performance Chemicals and Battery Materials improved.
Key Events · Earnings and Guidance · CBT
-
FY2027 Guidance Set Below FY2026
Management guided fiscal 2027 adjusted EPS to $6.15 to $6.75, against $6.42 reported for fiscal 2026 — a midpoint of $6.45 that implies essentially no growth.
-
Q4 Adjusted EPS $1.61, GAAP $1.25
Fourth-quarter net sales rose to $1,009 million from $899 million, but GAAP EPS of $1.25 absorbed $0.36 per share of certain items, mostly restructuring, leaving adjusted EPS at $1.61 versus $1.70 a year earlier.
-
Reinforcement Materials Profit Drops $32M
Segment EBIT fell to $87 million in the quarter from $119 million, driven by lower gross profit per ton after the calendar 2026 customer agreements, partly offset by 5% higher volumes.
-
Performance Chemicals and Battery Offset Weakness
Performance Chemicals EBIT rose $18 million to $60 million on better product mix and lower costs; Battery Materials delivered $43 million of EBITDA for fiscal 2026.
Analysis · CBT · Industrial Applications And Services
The forward number is what matters: management set fiscal 2027 adjusted EPS at $6.15 to $6.75, a range whose midpoint sits below the $6.42 just reported, so the company is guiding to flat-to-lower earnings rather than a rebound. Cabot closed fiscal 2026 with fourth-quarter adjusted EPS of $1.61, up from a GAAP $1.25 that carried $0.36 per share of restructuring charges, and full-year adjusted EPS of $6.42 versus $7.25 last year. The mix explains the pressure — Reinforcement Materials fourth-quarter EBIT fell $32 million year over year to $87 million on weaker gross profit per ton from the calendar 2026 customer agreements, while Performance Chemicals EBIT rose $18 million to $60 million. Battery Materials reached $43 million of EBITDA for the year, and the company signed the $50 million DOE grant agreement for conductive additives capacity in Louisiana and Texas, which is the growth story management is leaning on. Cash generation remains solid at $421 million from operations, funding $207 million of capex, $97 million of dividends and $146 million of buybacks, with net debt to EBITDA at 1.4 times.
How filings like this one have moved
In the 30 days to Nov 2, 2026, 32.7% of the 1910 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CBT was trading at $74.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $58.33 to $94.53. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.